Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
Clinical trial NCT03600623 · TERMINATED
Trial details
- NCT number
- NCT03600623
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2020-07-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.